{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:04:07Z","timestamp":1770487447658,"version":"3.49.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Psiquiatr\u00eda  y Salud Mental"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.rpsm.2016.01.011","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T08:33:03Z","timestamp":1459672383000},"page":"33-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hospitalizaciones y an\u00e1lisis econ\u00f3mico en pacientes psic\u00f3ticos con palmitato de paliperidona de larga duraci\u00f3n"],"prefix":"10.1016","volume":"10","author":[{"given":"Jes\u00fas E.","family":"Mesones-Peral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Gurillo-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari Paz","family":"S\u00e1nchez-Sicilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Gri\u00f1ant-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpsm.2016.01.011_bib0070","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","article-title":"Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia","volume":"161","author":"Gilmer","year":"2004","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0075","first-page":"266","article-title":"Hospitalization rates in patients during long-term treatment with long-acting risperidone injection","volume":"5","author":"Chue","year":"2005","journal-title":"J Appl Res."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0080","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1185\/03007995.2011.595000","article-title":"Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone-palmitate: Results from a clinical trial with a 52-week open-label extension (OLE)","volume":"27","author":"Kozma","year":"2011","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0085","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/npp.2010.79","article-title":"A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia","volume":"35","author":"Nasrallah","year":"2010","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10198-006-0350-5","article-title":"The costs of schizophrenia in Spain","volume":"7","author":"Oliva-Moreno","year":"2006","journal-title":"Eur J Health Econ."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-244X-10-2","article-title":"The cost of relapse and the predictors of relapse in the treatment of schizophrenia","volume":"10","author":"Ascher-Svanum","year":"2010","journal-title":"BMC Psychiatry."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11414-013-9329-z","article-title":"Healthcare cost reductions associated with the use of LAI formulations of antipsychotic medications versus oral among patients with schizophrenia","volume":"40","author":"Lin","year":"2013","journal-title":"J Behav Health Serv Res."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3111\/13696998.2014.1001514","article-title":"Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics","volume":"18","author":"Baser","year":"2015","journal-title":"J Med Econ."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0110","unstructured":"Decreto Legislativo 1\/2005, de 25 de febrero, del Consell de la Generalitat, por el que se aprueba el Texto Refundido de la Ley de Tasas de la Generalitat. DOCV n\u00fam. 4971 de 22 de marzo de 2005."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2165\/00023210-200216070-00004","article-title":"Relapse and rehospitalisation rates in patients with schizophrenia: Effects of second generation antipsychotics","volume":"16","author":"Csernansky","year":"2002","journal-title":"CNS Drugs."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0120","unstructured":"Janssen Scientific Affairs. Clinical Study Report. A randomized, double-blind, placebo-controlled, parallel-group study of paliperidone palmitate evaluating time to relapse in subjects with schizoaffective disorder (PRIME). Data on File. Raritan, NJ: Janssen Scientific Affairs, LLC; 2014."},{"key":"10.1016\/j.rpsm.2016.01.011_bib0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4088\/JCP.14m09416","article-title":"Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder","volume":"76","author":"Fu","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.rpsm.2016.01.011_bib0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/YIC.0000000000000077","article-title":"A retrospective observational study of the effectiveness of paliperidone palmitate on acute inpatient hospitalization rates","volume":"30","author":"Bressington","year":"2015","journal-title":"Int Clin Psychopharmacol."}],"container-title":["Revista de Psiquiatr\u00eda  y Salud Mental"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989116000410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1888989116000410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:30:46Z","timestamp":1761823846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1888989116000410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1888989116000410"],"URL":"https:\/\/doi.org\/10.1016\/j.rpsm.2016.01.011","relation":{},"ISSN":["1888-9891"],"issn-type":[{"value":"1888-9891","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospitalizaciones y an\u00e1lisis econ\u00f3mico en pacientes psic\u00f3ticos con palmitato de paliperidona de larga duraci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Revista de Psiquiatr\u00eda  y Salud Mental","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpsm.2016.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEP y SEPB. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}